bisnafide has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrens, CH; Cheshire, PJ; Dexter, DL; Gross, JL; Hallman, JC; Houghton, JA; Houghton, PJ; McRipley, RJ; Sun, JH | 1 |
| Brogdon, BL; Garner, DM; Gray, JE; Lai, CM; Peterman, VC; Pieniaszek, HJ | 1 |
| Avery, L; Bowman, L; Pappo, A; Pratt, CB; Stewart, CF; Thompson, J; Zamboni, WC | 1 |
1 trial(s) available for bisnafide and Neoplasms
| Article | Year |
|---|---|
Phase I study of DMP 840 in pediatric patients with refractory solid tumors.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Humans; Isoquinolines; Mesylates; Neoplasms; Thrombocytopenia; Treatment Outcome | 1998 |
2 other study(ies) available for bisnafide and Neoplasms
| Article | Year |
|---|---|
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers.
Topics: Adenocarcinoma; Adolescent; Adult; Analysis of Variance; Animals; Antineoplastic Agents; Child; Colonic Neoplasms; Drug Resistance; Female; Humans; Isoquinolines; Mesylates; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Neoplasms; Rhabdomyosarcoma; Topoisomerase I Inhibitors; Treatment Outcome; Tumor Cells, Cultured | 1994 |
Determination of bisnafide, a novel bis-naphthalimide anticancer agent, in human plasma by high-performance liquid chromatography with UV detection.
Topics: Antineoplastic Agents; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Humans; Isoquinolines; Mesylates; Neoplasms; Spectrophotometry, Ultraviolet; Time Factors | 1998 |